DUBLIN, Sept. 9, 2020 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that that its Chief Executive
Officer, Richard Pops, will
participate in a fireside chat at the Cantor
Virtual Global Healthcare Conference on Wednesday, Sept. 16, 2020 at 10:40 a.m. ET (3:40 p.m.
BST). The webcast may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical
company developing innovative medicines in the fields of
neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on addiction and
schizophrenia, and a pipeline of product candidates in development
for schizophrenia, bipolar I disorder, neurodegenerative disorders
and cancer. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
View original content to download
multimedia:http://www.prnewswire.com/news-releases/alkermes-to-take-part-in-cantor-virtual-global-healthcare-conference-301126833.html
SOURCE Alkermes plc